3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
13
Myelodysplastic Syndromes
5
Advanced Solid Tumors
5
Advanced Solid Tumour
4
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Small Cell Lung Carcinoma
2
Recurrence
2
Multiple Myeloma
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Solid Tumor
2
Advanced Lung Cancer
2
Unresectable Locally Recurrent Breast Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Non-small Lung Cancer
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Multiple Sclerosis
1
Metastatic Solid Tumors
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Idiopathic Pulmonary Fibrosis
1
Digestive System Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Depression
1
Interventions
X-Rays
6
Specimen Handling
6
Cyclophosphamide
6
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
4
fludarabine
3
Nuclear Medicine Department, Hospital
3
Doxorubicin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
mifamurtide
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
cabozantinib
2
Methotrexate
2
Mesna
2
Ifosfamide
2
Gemcitabine
2
Cisplatin
2
trastuzumab deruxtecan
1
tazemetostat
1
talazoparib
1
selinexor
1
pembrolizumab
1
pazopanib
1
palbociclib
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Injections
×
30 days
×
Clear all
No trials found.